An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia

Developmental Neurobiology

Volumn 74, Issue 9, 2014, Pages 907-917

  Chen, Li ^a,b   Perez, Stephanie M ^a   Lodge, Daniel J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Hippocampus; MAM rat; Parvalbumin; Preadolescent; Schizophrenia

Indexed keywords

METHYLAZOXYMETHANOL ACETATE; AMPHETAMINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; PARVALBUMIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; FEMALE; HIPPOCAMPUS; LOCOMOTION; NONHUMAN; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PRIORITY JOURNAL; PUBERTY; QUANTITATIVE ANALYSIS; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; VENTRAL TEGMENTUM; WESTERN BLOTTING; ACTION POTENTIAL; ANIMAL; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOTOR ACTIVITY; NERVE TRACT; PATHOPHYSIOLOGY; PHYSIOLOGY; SEXUAL MATURATION; SPRAGUE DAWLEY RAT;

ACTION POTENTIALS; AMPHETAMINE; ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AGENTS; DOPAMINERGIC NEURONS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; METHYLAZOXYMETHANOL ACETATE; MOTOR ACTIVITY; NEURAL PATHWAYS; PARVALBUMINS; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA; SEXUAL MATURATION; VENTRAL TEGMENTAL AREA;

EID: 84904459161     PISSN: 19328451     EISSN: 1932846X     Source Type: Journal    
DOI: 10.1002/dneu.22172     Document Type: Article

References (55)

1. Abdul-Monim Z, Neill JC, Reynolds GP. 2007. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. J Psychopharmacol 21:198-205.
2. Abi-Dargham A. 2004. Do we still believe in the dopamine hypothesis? New data bring new evidence. Int J Neuropsychopharmacol 7 Suppl 1:S1-S5.
3. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, Weiss R, et al. 2000. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci 97:8104-8109.
4. Abi-Dargham A, van de Giessen E, Slifstein M, Kegeles LS, Laruelle M. 2009. Baseline and amphetamine-stimulated dopamine activity are related in drug-naive schizophrenic subjects. Biol Psychiatry 65:1091-1093.
5. Amitai N, Kuczenski R, Behrens MM, Markou A. 2012. Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats. Neuropharmacology 62:1422-1431.
6. Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, Dugan LL. 2007. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 318:1645-1647.
7. Bell DS. 1965. Comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry 111:701-707.
8. Benoit-Marand M, O'Donnell P. 2008. D2 dopamine modulation of corticoaccumbens synaptic responses changes during adolescence. Eur J Neurosci 27:1364-1372.
9. Bolanos CA, Glatt SJ, Jackson D. 1998. Subsensitivity to dopaminergic drugs in periadolescent rats: A behavioral and neurochemical analysis. Dev Brain Res 111:25-33.
10. Demjaha A, Valmaggia L, Stahl D, Byrne M, McGuire P. 2012. Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis. Schizophr Bull 38:351-359.
11. Du Y, Grace AA. 2013. Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia. Neuropsychopharmacology 38:1881-1888.
12. Floresco SB, West AR, Ash B, Moore H, Grace AA. 2003. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 6:968-973.
13. Franois J, Ferrandon A, Koning E, Angst MJ, Sandner G, Nehlig A. 2009. Selective reorganization of GABAergic transmission in neonatal ventral hippocampal-lesioned rats. Int J Neuropsychopharmacol 12:1097-1110.
14. Frantz KJ, O'Dell LE, Parsons LH. 2007. Behavioral and neurochemical responses to cocaine in periadolescent and adult rats. Neuropsychopharmacology 32:625-637.
15. Fusar-Poli P, Deste G, Smieskova R, Barlati S, Yung AR, Howes O, Stieglitz RD, et al. 2012. Cognitive functioning in prodromal psychosis: A meta-analysis. Arch Gen Psychiatry 69:562-571.
16. Grace AA, Bunney BS. 1983. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-1. Identification and characterization. Neuroscience 10:301-315.
17. Grace AA, Bunney BS. 1984. The control of firing pattern in nigral dopamine neurons: Burst firing. J Neurosci 4:2877-2890.
18. Grace AA, Floresco SB, Goto Y, Lodge DJ. 2007. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 30:220-227.
19. Hafner H, Riecher-Rossler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A, Fatkenheuer B, et al. 1992. IRAOS: An instrument for the assessment of onset and early course of schizophrenia. Schizophr Res 6:209-223.
20. Heckers S, Rauch SL, Goff D, Savage CR, Schacter DL, Fischman AJ, Alpert NM. 1998. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat Neurosci 1:318-323.
21. Howes OD, Bose SK, Turkheimer F, Valli I, Egerton A, Valmaggia LR, Murray RM, et al. 2011. Dopamine synthesis capacity before onset of psychosis: A prospective [18F]-DOPA PET imaging study. Am J Psychiatry 168:1311-1317.
22. Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, Bramon-Bosch E, et al. 2009. Elevated striatal dopamine function linked to prodromal signs of schizophenia. Arch Gen Psychiatry 66:13-20.
23. Huppe-Gourgues F, O'Donnell P. 2012a. D 1-NMDA receptor interactions in the rat nucleus accumbens change during adolescence. Synapse 66:584-591.
24. Huppe-Gourgues F, O'Donnell P. 2012b. Periadolescent changes of D 2-AMPA interactions in the rat nucleus accumbens. Synapse 66:1-8.
25. Jenkins TA, Harte MK, Reynolds GP. 2010. Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the rat. Neurosci Lett 471:144-147.
26. Konradi C, Yang CK, Zimmerman EI, Lohmann KM, Gresch P, Pantazopoulos H, Berretta S, Heckers S. 2011. Hippocampal interneurons are abnormal in schizophrenia. Schizophr Res 131:165-173.
27. Korenbrot CC, Huhtaniemi IT, Weiner RI. 1977. Preputial seperation as an external sign of pubertal development in the male rat. Biol Reprod 17:298-303.
28. Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Carpenter WT, McMahon R. 2006. Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. Neuropsychopharmacology 31:221-230.
29. Lanier LP, Isaacson RL. 1977. Early developmental changes in the locomotor response to amphetamine and their relation to hippocampal function. Brain Res Brain Res Rev 126:567-575.
30. Laruelle M, Abi-Dargham A. 1999. Dopamine as the wind of psychotic fire: New evidence from brain imaging studies. J Psychopharmacol 13:358-371.
31. Lewis DA, Hashimoto T, Volk DW. 2005. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6:312-324.
32. Lieberman JA, Kane JM, Alvir J. 1987. Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology (Berl) 91:415-433.
33. Lodge DJ. 2011. The medial prefrontal and orbitofrontal cortices differentially regulate dopamine system function. Neuropsychopharmacology 36:1227-1236.
34. Lodge DJ, Behrens MM, Grace AA. 2009. A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci 29:2344-2354.
35. Lodge DJ, Grace AA. 2006a. The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation. Neuropsychopharmacology 31:1356-1361.
36. Lodge DJ, Grace AA. 2006b. The laterodorsal tegmentum is essential for burst firing of ventral tegmental area dopamine neurons. Proc Natl Acad Sci USA 103:5167-5172.
37. Lodge DJ, Grace AA. 2007. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. J Neurosci 27:11424-11430.
38. Lodge DJ, Grace AA. 2008. Amphetamine activation of hippocampal drive of mesolimbic dopamine neurons: A mechanism of behavioral sensitization. J Neurosci 28:7876-7882.
39. Lodge DJ, Grace AA. 2011. Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia. Trends Pharmacol Sci 32:507-513.
40. Malaspina D, Storer S, Furman V, Esser P, Printz D, Berman A, Lignelli A, et al. 1999. SPECT study of visual fixation in schizophrenia and comparison subjects. Biol Psychiatry 46:89-93.
41. Medoff DR, Holcomb HH, Lahti AC, Tamminga CA. 2001. Probing the human hippocampus using rCBF: Contrasts in schizophrenia. Hippocampus 11:543-550.
42. Meltzer HY, Matsubara S, Lee JC. 1989. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pK(i) values. J Pharmacol Exp Ther 251:238-246.
43. Moore H, Jentsch JD, Ghajarnia M, Geyer MA, Grace AA. 2006. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: Implications for the neuropathology of schizophrenia. Biol Psychiatry 60:253-264.
44. Paxinos G, Watson C. 1986. The Rat Brain in Stereotaxic Coordinates. Sydney, Australia: Academic Press Australia.
45. Penschuck S, Flagstad P, Didriksen M, Leist M, Michael-Titus AT. 2006. Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia. Eur J Neurosci 23:279-284.
46. Perez SM, Lodge DJ. 2012. Aberrant dopamine D2-like receptor function in a rodent model of schizophrenia. J Pharmacol Exp Ther 343:288-295.
47. Schobel SA, Lewandowski NM, Corcoran CM, Moore H, Brown T, Malaspina D, Small SA. 2009. Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Arch Gen Psychiatry 66:938-946.
48. Solbach S, Celio MR. 1991. Ontogeny of the calcium binding protein parvalbumin in the rat nervous system. Anat Embryol 184:103-124.
49. Taepavarapruk P, Floresco SB, Phillips AG. 2000. Hyperlocomotion and increased dopamine efflux in the rat nucleus accumbens evoked by electrical stimulation of the ventral subiculum: Role of ionotropic glutamate and dopamine D1 receptors. Psychopharmacology (Berl) 151:242-251.
50. Teicher MH, Andersen SL, Hostetter Jr JC. 1995. Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Dev Brain Res 89:167-172.
51. Tseng KY, Lewis BL, Lipska BK, O'Donnell P. 2007. Post-pubertal disruption of medial prefrontal cortical dopamine-glutamate interactions in a developmental animal model of schizophrenia. Biol Psychiatry 62:730-738.
52. Tseng KY, O'Donnell P. 2007. Dopamine modulation of prefrontal cortical interneurons changes during adolescence. Cereb Cortex 17:1235-1240.
53. Valenti O, Cifelli P, Gill KM, Grace AA. 2011. Antipsychotic drugs rapidly induce dopamine neuron depolarization block in a developmental rat model of schizophrenia. J Neurosci 31:12330-12338.
54. Wang CZ, Yang SF, Xia Y, Johnson KM. 2008. Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons. Neuropsychopharmacology 33:2442-2455.
55. Zakharova E, Leoni G, Kichko I, Izenwasser S. 2009. Differential effects of methamphetamine and cocaine on conditioned place preference and locomotor activity in adult and adolescent male rats. Behav Brain Res 198:45-50.